Parmax Pharma Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
11.22 Cr.
|
P/BV
|
2.18
|
Book Value (Rs.)
|
13.75
|
52 Week High/Low (Rs.)
|
38/24
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -0.28 | 0.38 | 2.02 | 1.15 | 0.21 |
Diluted EPS (Rs.) | -0.28 | 0.38 | 2.02 | 1.15 | 0.21 |
Cash EPS (Rs.) | 3.99 | 4.66 | 6.06 | 3.23 | 2.49 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 13.15 | 13.38 | 13.07 | 11.38 | 10.41 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 13.15 | 13.38 | 13.07 | 11.38 | 10.41 |
Revenue From Operations / Share (Rs.) | 34.65 | 41.00 | 58.87 | 47.03 | 26.99 |
PBDIT / Share (Rs.) | 5.15 | 5.89 | 7.87 | 4.19 | 2.61 |
PBIT / Share (Rs.) | 0.93 | 1.55 | 3.51 | 1.93 | 0.29 |
PBT / Share (Rs.) | 0.10 | 0.68 | 2.71 | 1.64 | 0.22 |
Net Profit / Share (Rs.) | -0.23 | 0.31 | 1.69 | 0.96 | 0.17 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 14.87 | 14.36 | 13.37 | 8.90 | 9.66 |
PBIT Margin (%) | 2.69 | 3.77 | 5.96 | 4.09 | 1.08 |
PBT Margin (%) | 0.29 | 1.66 | 4.61 | 3.49 | 0.81 |
Net Profit Margin (%) | -0.67 | 0.77 | 2.87 | 2.04 | 0.65 |
Return on Networth / Equity (%) | -1.77 | 2.37 | 12.96 | 8.46 | 1.69 |
Return on Capital Employeed (%) | 3.96 | 6.46 | 13.60 | 8.43 | 1.32 |
Return On Assets (%) | -0.59 | 0.78 | 3.31 | 2.03 | 0.39 |
Long Term Debt / Equity (X) | 0.76 | 0.75 | 0.93 | 0.99 | 1.13 |
Total Debt / Equity (X) | 0.76 | 0.75 | 0.93 | 0.99 | 1.13 |
Asset Turnover Ratio (%) | 0.86 | 0.89 | 1.20 | 1.03 | 0.66 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.05 | 0.89 | 0.91 | 0.86 | 0.92 |
Quick Ratio (X) | 0.45 | 0.50 | 0.56 | 0.61 | 0.51 |
Inventory Turnover Ratio (X) | 1.54 | 1.97 | 4.02 | 3.35 | 1.09 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 6.22 | 6.79 | 9.89 | 14.64 | 35.67 |
Interest Coverage Ratio (Post Tax) (%) | 0.71 | 1.37 | 3.13 | 4.37 | 3.42 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 17.59 | 21.65 | 18.69 | 10.39 | 11.39 |
EV / Net Operating Revenue (X) | 1.14 | 1.19 | 0.71 | 0.49 | 0.94 |
EV / EBITDA (X) | 7.67 | 8.26 | 5.33 | 5.57 | 9.81 |
MarketCap / Net Operating Revenue (X) | 0.87 | 0.99 | 0.60 | 0.34 | 0.64 |
Price / BV (X) | 2.31 | 3.05 | 2.72 | 1.41 | 1.66 |
Price / Net Operating Revenue (X) | 0.87 | 0.99 | 0.60 | 0.34 | 0.64 |
EarningsYield | -0.01 | 0.01 | 0.04 | 0.06 | 0.01 |